This Week In Weed – 4 November 2018

Supply shortage in Canada deepens

Demand continues to outstrip supply two weeks after Canada became the first G20 country to legalise cannabis.

Rosalie Wyonch, a policy analyst at the CD Howe Institute, said the problem has developed “faster than I would have expected”.

When Colorado legalised recreational cannabis, it took some three years for supply to finally catch up to demand, and Canada could expect a similar delay, said Wyonch.

Greek billionaire eyes Edinburgh cannabis shop

A Greek billionaire is looking to set up a shop selling cannabis products on Princes Street in Edinburgh. Alki David, one of the world’s richest men, runs a company that bottles and distributes Coca-Cola in 28 countries.

Last year he set up a business selling cannabis oil. The 50-year-old says he aims to open the shop within three months. He said: “Plant medicine is revolutionary. It has improved so many lives to the point of miracles happening.

Coca-Cola u-turn?

Coca-Cola CEO James Quincey has said that the company “doesn’t have any plans at this stage” to enter the CBD market.

Coke said in September that it was “closely watching” the growth of CBD as a possible “infusion” ingredient for so-called wellness beverages. At the same time, rumors swirled that Coke was considering an investment in Canadian cannabis company Aurora.

Epidiolex now prescribable in all US states

GW Pharma’s Epidiolex can now be prescribed in all 50 US states, the first plant-derived, cannabis-based medicine to be made so. The medication consists of highly-purified, plant-derived cannabidiol (CBD).

The twice daily oral solution was approved by the FDA for the treatment of seizures associated with either Lennox-Gastaut syndrome (LGS) or Dravet syndrome in patients aged two years and older in June of this year.

    Leave a Reply